Navigation Links
Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
Date:3/2/2011

SAN DIEGO, March 2, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Cowen & Co. 31st Annual Health Care Conference in Boston.

The live presentation takes place on Wednesday, March 9, 2011 at 10:15 a.m. Eastern Time / 7:15 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
2. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
3. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
4. Neurocrine Biosciences Announces Conference Call and Webcast on Worldwide Agreement With Abbott on Elagolix
5. Neurocrine Biosciences to Present at the Jefferies 2010 Global Life Sciences Conference and the 9th Annual Needham Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
7. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
8. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
9. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
10. Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain
11. Neurocrine Biosciences Amends Corporate Headquarters Lease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... DUBLIN , Sept. 22, 2014 ... the "Global and Chinese Microcrystalline Cellulose Industry Report ... The Global and Chinese Microcrystalline Cellulose Industry Report 2014 ... state of the global microcrystalline cellulose industry with a ... provides a basic overview of the industry including definitions, ...
(Date:9/22/2014)... Washington, D.C (PRWEB) September 22, 2014 ... the top privately held biotechnology companies of 2014. ... of companies before selecting this year’s winners. Those ... private biotechnology companies in the industry. , ... a new group of Fierce 15 companies," said Carroll. ...
(Date:9/22/2014)... Sept. 22, 2014 Synageva BioPharma ... a biopharmaceutical company developing therapeutic products for rare ... Bazemore as Chief Operating Officer.  Reporting directly ... Chief Executive Officer, Robert will oversee the planned ... sebelipase alfa for LAL Deficiency, and will have ...
(Date:9/21/2014)... Chemical Sciences play a significant role ... air and safe water, healthy food, and dependable ... food scientists, educators, and scientists have a great ... of Chemistry for the national development, and to ... the fastest emerging Sciences, accelerating with a tremendous ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3
... , , Mark Churchill 1 , Mark Harrison 1 , , ... , 1 Thermo Finnigan, Stafford House, 1 Boundary Park, Boundary Way, ... Aker University Hospital, Hormone Laboratory, Section for Doping Analysis,Trondheimsveien, , N-0514, Oslo, Norway, ... , Monitoring Clenbuterol in Humans , , , ...
... , , , , , , , ... , Features and benefits , , , , , ... transfection of siRNA for effective gene silencing , Quick and easy setup ... for absence of RNase activity , , , , , ...
... , , , , QIAshredder spin columns are designed for simple and rapid ... , , , , ... , , , ... tissue lysates, , plant cell or tissue lysates, white blood cell lysates, ...
Cached Biology Technology:Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 2Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 3Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 4Improved Quantitative Selectivity of Clenbuterol in Human Urine using , High Resolution on the TSQ Quantum Mass Spectrometer 5TransMessenger Transfection Reagent 2TransMessenger Transfection Reagent 3QIAshredder Homogenizer 2
(Date:9/21/2014)... developed a protein therapy that disrupts the process that ... sites, travel through the blood stream and start aggressive ... known as metastasis, can cause cancer to spread with ... succumb to cancer fall prey to metastatic forms of ... bioengineering who describes a new therapeutic approach in ...
(Date:9/19/2014)... The sense of fairness did not evolve for the ... reap the benefits of continued cooperation, so say Frans ... a review article about inequity aversion (IA), which is ... review is published in Science . , ... 35 IA-related studies to address their hypothesis that it ...
(Date:9/18/2014)... A new GSA Bulletin study uses ... Rio Puerco and Chaco Wash in northern New Mexico, ... salt cedar and willow, investigators were able to precisely ... They then combined this data with aerial imagery, LiDAR, ... of these arroyos. , Arroyos are deep, oversized channels ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... When researchers sequence the RNA of cancer cells, they can ... RNA. That can help lead them to the gene or protein ... a few known instigators, what does it mean? Is there more ... fast enough? What part of the biological equilibrium is off? ...
... the first time that primates modify their body movements to ... Humans unconsciously modify their movements to be in synchrony with ... in step or clap in unison at the end of ... facilitate human interaction. Researchers from the RIKEN Brain Science Institute ...
... patients with an inherited heart condition known as arrhythmogenic ... problem until they,re in their early 20s. The lack ... for researchers to study how ARVD/C evolves or to ... 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps ...
Cached Biology News:New technique sheds light on RNA 2Primates too can move in unison 2Patients' own skin cells are transformed into heart cells to create 'disease in a dish' 2Patients' own skin cells are transformed into heart cells to create 'disease in a dish' 3
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
... Anti-NY-ESO-1, clone E978 ... : NM_001327 Immunogen ... protein Formulation: mouse ascites ... Quality Assurance: routinely evaluated ...
R26.4C...
Biology Products: